SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-23-060233
Filing Date
2023-03-06
Accepted
2023-03-03 17:51:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM d431958dposam.htm POS AM 257051
2 EX-23.2 d431958dex232.htm EX-23.2 1860
3 GRAPHIC g431958g00n03.jpg GRAPHIC 28560
4 GRAPHIC g431958g00n30.jpg GRAPHIC 30476
  Complete submission text file 0001193125-23-060233.txt   335372
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-263226 | Film No.: 23706288
SIC: 2834 Pharmaceutical Preparations